Partnerships

We develop transformative medicines for severe diseases using our Confo® GPCR technology.
In addition to advancing our own portfolio, we are engaging in strategic partnerships with other biopharmaceutical organizations in non-competing disease areas. We have secured revenue-generating drug discovery partnerships with leading pharma companies, as well as drug discovery collaborations in support of our proprietary programs.